ENTPD1 and prostate cancer: In DU145 prostate cancer model, exosomes expressing CD39 and CD73 secreted from prostate cancer cells inhibited DC activities, resulting in an immunosuppressive environment to impede the priming and activation of CD8+ T cells [51].